Mangalam Seeds approves 90% Nutrifeeds sale and Bioseeds exit

Mangalam Seeds Limited approved on 6 November 2026 the proposed sale of 90% of Mangalam Nutrifeeds Private Limited and a full exit from its 25% holding in Sharayu Mangalam Bioseeds Private Limited. Mangalam Seeds has not disclosed consideration for either transaction, which remains subject to definitive agreements and customary closing formalities.

What has Mangalam Seeds approved?

Mangalam Seeds has approved two proposed equity divestments: a 90% sale of Mangalam Nutrifeeds and the sale of its entire 25% interest in Sharayu Mangalam Bioseeds. The board approved both proposals at its meeting on 6 November 2026, which began at 4:45 p.m. and concluded at 6:15 p.m.

Mangalam Nutrifeeds is currently a wholly owned subsidiary, so Mangalam Seeds' holding would decline from 100% to 10% on completion. The filing says Mangalam Nutrifeeds would cease to be a subsidiary subject to completion of the transaction and the resulting control position.

Sharayu Mangalam Bioseeds is currently an associate in which Mangalam Seeds holds 25%. On completion of the proposed disposal, Mangalam Seeds would hold no equity in the company and Sharayu Mangalam Bioseeds would cease to be an associate.

The proposals are board approvals, not announcements of completed sales. The 90% reduction in the Nutrifeeds holding differs from the Bioseeds transaction because Mangalam Seeds would retain a 10% investment in Nutrifeeds but would fully relinquish its 25% Bioseeds stake.

Who are the proposed buyers of Mangalam Seeds' stakes?

Mangalam Seeds named Anil Danga and Sureshkumar Sharma as the proposed purchasers for the 90% Mangalam Nutrifeeds disposal. The filing states that neither person is related to Mangalam Seeds' promoter or promoter group, but it does not state how the 90% stake would be split between them.

Ramchandra Gajanan Nake is the proposed purchaser for Mangalam Seeds' full 25% Sharayu Mangalam Bioseeds stake. Mangalam Seeds also stated that Nake is not related to its promoter or promoter group, and the filing does not disclose a purchase-price allocation or payment structure.

Mangalam Seeds classified both transactions as not being related-party transactions. It also reported that no shares would be issued to purchasers and marked disclosures relating to board nominees, potential conflicts of interest and slump-sale information as not applicable.

The buyer disclosures identify three proposed purchasers across the two transactions, but not final contractual terms. The two Nutrifeeds buyers contrast with the single named purchaser for the Bioseeds holding, while each proposed transaction remains subject to an agreement on a mutually agreed date.

What did the two investees contribute in FY 2025-26?

Sharayu Mangalam Bioseeds contributed turnover of Rs 1.161125 crore, or 1.03%, in financial year 2025-26, while Mangalam Nutrifeeds recorded nil turnover contribution. The disclosed comparison means the associate reported turnover contribution in that year even though Mangalam Seeds held only 25% of it, versus 100% of Nutrifeeds.

Both entities had negative disclosed net-worth contributions in FY 2025-26. Mangalam Nutrifeeds' contribution was negative Rs 4.8201062 lakh, or negative 0.05%, whereas Sharayu Mangalam Bioseeds' contribution was negative Rs 55.816065 lakh, or negative 0.62%.

The negative net-worth contribution reported for Sharayu Mangalam Bioseeds was larger than that for Mangalam Nutrifeeds, while the associate alone had disclosed turnover contribution. These figures are contribution data reported for FY 2025-26, rather than valuations of either investee or estimates of sale proceeds.

Mangalam Seeds did not disclose operating assets, liabilities, earnings, or a valuation for either company in the announcement dated 6 November 2026. Consequently, the FY 2025-26 turnover and net-worth contribution figures cannot establish what either buyer will pay for the 90% Nutrifeeds stake or the 25% Bioseeds stake.

What consideration and completion steps remain?

Mangalam Seeds has not disclosed a rupee consideration for either proposed sale. For the Nutrifeeds divestment and the Bioseeds exit, it said consideration would be determined under terms mutually agreed between the parties in definitive agreements, subject to customary adjustments and other customary transaction terms.

The company has not set a disclosed signing or closing date for either agreement. Instead, it said the definitive agreement for each sale will be executed on a mutually agreed date, leaving the consideration, payment terms and transaction timetable unresolved as of 6 November 2026.

Completion of customary closing formalities is required before the transactions take effect. For Nutrifeeds, the filing additionally ties the loss of subsidiary status to the resulting control position, even though Mangalam Seeds has stated it would retain 10% equity after the proposed 90% sale.

For Bioseeds, the stated ownership outcome is definitive if the transaction completes: Mangalam Seeds would move from 25% equity ownership to nil. The announced distinction is therefore between a reduced financial interest in Nutrifeeds and an intended complete exit from Bioseeds, with definitive agreements still required for both.

How does the announcement relate to Mangalam Seeds' results release?

Mangalam Seeds issued the divestment approvals alongside its approval of unaudited standalone and consolidated financial results for the second quarter and half year ended 30 September 2026. The filing does not quantify a gain, loss or balance-sheet effect from either proposed disposal because consideration has not yet been determined.

The company also said its trading window would remain closed until 48 hours after the announcement of its unaudited financial results, under the Securities and Exchange Board of India’s 2015 insider-trading regulations. That disclosure concerns the timing of the results announcement and does not specify a completion date for either divestment.

The 6 November 2026 filing provides ownership changes and FY 2025-26 contribution data, but not pro forma consolidated financial statements after the transactions. The effect on reported consolidation will therefore depend on the definitive terms, closing and the control assessment for the remaining 10% Nutrifeeds interest.

Conclusion

The approved proposals would materially change Mangalam Seeds' relationship with two investees: it plans to reduce its Nutrifeeds holding from 100% to 10% and exit Bioseeds from 25% to nil. In FY 2025-26, Bioseeds reported Rs 1.161125 crore of turnover contribution while Nutrifeeds reported nil, and both reported negative net-worth contributions.

The next disclosed steps are execution of definitive agreements on mutually agreed dates, determination of consideration and customary adjustments, followed by closing formalities. Investors should watch for Mangalam Seeds' future disclosure of transaction values, final purchaser terms, completion dates and confirmation of the subsidiary and associate status changes.